ClinicalTrials.gov
public full text
Public Domain
Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia
The purpose of the study is to determine the reduction of LDL-cholesterol level after treatment with 50 mg per day of lapaquistat acetate once daily (QD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia#1308778
- Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol#1244232
- Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia#1464342
- Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.#899766
- Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia#1431785
Record · ID 1464636
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive